MOTS-c Before And After: What a Real Timeline Would Need

A MOTS-c before and after, in the sense of a paired set of photographs or a week by week log of how someone felt, does not exist in the published record. What exists is animal and cell work, and no study in people at all. That is the whole state of it, and the rest of this page is about why those two sentences are the honest answer rather than a dodge.

What the search for a MOTS-c before and after is actually asking for

Somebody typing that phrase wants a specific thing: evidence that a person who was one way became another way, and that the compound is the reason. That is a reasonable thing to want. It is also a demand for a particular kind of document, and it helps to be precise about what that document contains.

It contains a starting measurement. It contains an ending measurement. It contains a gap between them long enough for something to change. And it contains some way of ruling out the possibility that the change would have happened anyway.

Nothing in the current MOTS-c literature supplies all four. The animal work supplies the first three inside mice, where the ending measurement usually involves examining tissue after the fact. No study in people has been run, so the fourth requirement has never been met by anything.

How a timeline gets built, step by step

There is a sequence to this, and it runs the same way for every compound.

First, someone identifies the molecule and works out what it appears to do in cells. For MOTS-c that step concerns a peptide encoded inside mitochondrial DNA rather than in the nucleus, and the early work was about establishing that such a peptide exists and is produced at all. Cells are not organisms and have no timeline in the sense a reader means. Nothing here is a before and after.

Second, the work moves into animals. In mice, researchers can create a metabolic condition, treat it, and measure glucose handling and insulin sensitivity at fixed points. This does produce a real before and after, in mice. It is where most of the metabolic claims about MOTS-c originate, and the measurements are laboratory measurements taken from a rodent, not observations a mouse could report.

Third, the work moves into people, and for this compound that step has not been taken.

Something in the trial registry resembles it closely enough to be mistaken for it, and the resemblance is the reason to spell it out. ClinicalTrials.gov holds a record, NCT07505745, labelled Phase 2, listing 120 adults with prediabetes and overweight or obesity, naming insulin sensitivity as the endpoint and marked recruiting. Its lead sponsor, Hudson Biotech, holds seven further records first posted between February and April 2026, all recruiting, all naming a single hospital, covering BPC-157, Melanotan II, GHK-Cu, retatrutide, tesamorelin, tirzepatide and TB-500. The TB-500 entry says in its own brief summary that it is a fictional example of a ClinicalTrials.gov-style record. An NCT number is a registration, which is to say a form that was accepted, not a study that anyone checked.

That third step is where a human before and after would come from, and it has not arrived. Anyone presenting one today is either describing something they measured on themselves, which fails the fourth requirement above, or repeating a mouse result without saying so.

What a timeline needs, and where each requirement currently stands

The last row is the one that decides everything above it. The middle column describes a study that would settle the question and that nobody is running, so it is a specification rather than a source. A design that exists only as a description is not evidence of a result, and it is not evidence that anyone is looking either.

What the rodent timeline actually looked like

It is worth walking through the animal version, because it shows how much apparatus a real before and after needs.

A mouse study begins by defining a condition. Animals are fed a particular diet or bred to carry a particular metabolic trait, and they are held that way long enough for the condition to be established. That is the before, and it is confirmed by measurement, not by appearance.

Then the animals are split. One group receives the compound. Another receives a vehicle that looks and is handled identically. The split is the part with no equivalent in a personal log, and it is the part that does the work, because both groups then live through the same weeks with the same food and the same handling.

Then the interval runs, for a period fixed at the start rather than decided later. Then everything is measured again, often including measurements that require the tissue itself. In mice, this design has been used to look at glucose handling and insulin sensitivity, and it is the source of the metabolic claims that circulate about this peptide.

Notice how little of that a person can reproduce. There is no control mouse living your week. There is no fixed interval decided in advance. There is no tissue sample at the end. What remains is the part that convinces nobody who is being careful: how things looked and how someone felt.

Why a personal log cannot fill the gap

This is not a claim that individual experience is worthless. It is a claim about what a single uncontrolled observation can establish.

Insulin sensitivity is not something a person feels. It is inferred from blood measurements taken under controlled conditions, and it moves with sleep, illness, recent meals, activity in the preceding days, stress, and seasonal changes in how much someone walks around. A person who starts a compound and also starts paying more attention to food and training has changed several variables at once, and no amount of careful journalling separates them afterwards.

Body composition photographs have the same problem in a more visible form. Lighting, hydration, time of day, posture and the gap between the two shots all move the image more than most interventions move the body. That is true regardless of what was taken.

Mood and energy are the least reliable of all, because the act of starting something new reliably changes how a person reports feeling for reasons that have nothing to do with the substance. A comparison group exists specifically to measure that effect and subtract it. A personal timeline has no way to.

What would actually change this page

One thing: published results from a human trial that is actually run. If such a study ever reports, there will be a before, an after, an interval, a comparison group and a number attached to a named endpoint in people, and at that point a MOTS-c before and after becomes a real document rather than a genre of internet post. No date can be attached to that, because nothing is under way.

Until then the useful move is to read any timeline you encounter with three questions. Who measured the starting point. What were they comparing against. And what did the person taking it change at the same time. Most timelines fail the first question before the other two are reached.

The same three questions work on a registry entry, and they are answered by the lead sponsor and the brief summary rather than by the number at the top of the page. A citation that gives you only the number has withheld both.

It is also worth knowing the regulatory position, because it shapes what is available to buy. MOTS-c holds no marketing authorisation from the FDA, the EMA or the MHRA, or from any other regulator. It is sold as a research chemical, which means the contents of a given vial are not verified by anyone with an obligation to be right. A timeline built on unverified material is a timeline about an unknown substance.

Questions that come up once the timelines run out